Table 1 Baseline characteristics of patients with Graves’ disease, according to radioactive iodine dose administration 10–15 mCi vs 20 mCi
From: Prospective study to evaluate radioactive iodine of 20 mCi vs 10–15 mCi in Graves’ disease
RAI 10–15 mCi (N = 113) | RAI 20 mCi (N = 106) | P | |
|---|---|---|---|
Age (year) | 44.8 ± 13.5 | 45 ± 15.5 | 0.98 |
Sex (female/male) | 81/32 | 79/27 | 0.64 |
BMI (kg/m2) | 24 ± 4.9 | 24.5 ± 5 | 0.78 |
MMI dose (mg) | 7.5 (2.5–10) | 10 (5–15) | 0.15 |
MMI duration (months) | 28 (8.5–49.5) | 25 (6.8–39.8) | 0.41 |
Ophthalmopathy (n) | 15/113 | 13/106 | 0.82 |
Thyroid size (grams) | 54.9 ± 20.4 | 49.2 ± 24.2 | 0.23 |
TSH (uIU/mL) | 0.006 (0.005–0.032) | 0.01 (0.005–1.459) | 0.007* |
Free T3 (ng/dL) | 4.9 (3.5–9.6) | 4.2 (3.2–6.1) | 0.037* |
Free T4 (nd/dL) | 1.8 (1.3–2.7) | 1.4 (1–2.2) | 0.12 |